Edit
Axial Therapeutics
https://www.axialbiotherapeutics.com/Last activity: 02.04.2020
Active - Reference to Axial Therapeutics, Inc.
Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Total raised: $54.15M
Investors 1
| Date | Name | Website |
| - | Taiho Vent... | taihoventu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 20.06.2019 | Series B | $10M | Taiho Vent... |
| 27.02.2019 | Series B | $25M | - |
| 01.12.2016 | Series A | $19.15M | - |
Mentions in press and media 20
| Date | Title | Description |
| 02.04.2020 | Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T | → Sue Desmond-Hellmann will be joining Pfizer’s board of directors, four months after stepping down as CEO of the Bill and Melinda Gates Foundation. The American pharma giant has attracted a star-studded board, most recent... |
| 27.06.2019 | Gut-Targeted Therapeutics Company Axial Biotherapeutics Raises $10 Million | Axial Biotherapeutics, a biotech company dedicated to building gut-targeted therapeutics, announced it raised $10 million Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for n... |
| 21.06.2019 | How Slack Made Other Startup CEOs Wealthy: Term Sheet | SLACK SOARS Slack killed it. Paid Content You can't secure what you can't see From ExtraHop Yesterday, I noted that Accel had a big windfall thanks to Slack’s public market debut. But I read an interesting story in Forbes that talks about h... |
| 20.06.2019 | Axial Biotherapeutics Raises $10M in Series B Extension Funding | Axial Biotherapeutics, a Waltham, MA-based biotechnology company dedicated to building gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, raised $10m in Series B extension funding. Taiho Ventures made... |
| 20.06.2019 | Axial Biotherapeutics Announces $10M Investment from Taiho Ventures | WALTHAM, Mass.--(BUSINESS WIRE)--Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, today announced a direct inve... |
| 20.06.2019 | Axial Biotherapeutics Receives $10M | WALTHAM, MA, Axial Biotherapeutics today announced a direct investment of $10 million from Taiho Ventures. >> Click here for more funding data on Axial Biotherapeutics >> To export Axial Biotherapeutics funding data to PDF a... |
| 28.02.2019 | Axial Biotherapeutics nets $25M for clinical gut-brain axis studies into autism and Parkinson’s | Axial Biotherapeutics has raised $25 million to fund its programs aimed at the gut microbiome, for the treatment of Parkinson’s disease and autism spectrum disorder. Seventure Partners led the series B round, through its microbiome-focused ... |
| 27.02.2019 | Axial Biotherapeutics Raises $25M in Series B Financing | Axial Biotherapeutics, a Waltham, MA-based biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases, completed a $25m series B equity financing. The round was le... |
| 27.02.2019 | Axial Biotherapeutics nets $25M for clinical gut-brain axis studies into autism and Parkinson’s | Axial Biotherapeutics has raised $25 million to fund its programs aimed at the gut microbiome, for the treatment of Parkinson’s disease and autism spectrum disorder. Sponsored by Agilent Technologies How would you like to win free bench spa... |
| 27.02.2019 | Axial Biotherapeutics Finds $25M For Parkinson's, Autism Treatments | Pasadena-based Axial Biotherapeutics, a biotechnology company which is focused on developing treatments for Parkinson's disease and Autism Spectrum Disorder, has raised $25M in its Series B funding round, the company announced this morning.... |
Show more